首页> 美国卫生研究院文献>Molecular Pharmacology >Constitutive androstane receptor 1 is constitutively bound tochromatin and ‘primed’ for transactivation in hepatocytes
【2h】

Constitutive androstane receptor 1 is constitutively bound tochromatin and ‘primed’ for transactivation in hepatocytes

机译:本构雄激素受体1本构结合染色质和引发的肝细胞反式激活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The constitutive androstane receptor (CAR) is a xenobiotic sensor expressed in hepatocytes that activates genes involved in drug metabolism, lipid homeostasis, and cell proliferation. Much progress has been made in understanding the mechanism of activation of human CAR by drugs and xenobiotics. However, many aspects of the activation pathway remain to be elucidated. In this report, we have used viral constructs to express human CAR, its splice variants, and mutant CAR forms in hepatocytes from Car−/− mice in vitro and in vivo. We demonstrate CAR expression rescued the ability of Car−/− hepatocytes to respond to a wide range of CAR activators including phenobarbital. Additionally, two major splice isoforms of human CAR, CAR2 and CAR3, were inactive with almost all the agents tested. In contrast to the current model of CAR activation, ectopic CAR1 is constitutively localized in the nucleus and is loaded onto Cyp2b10 gene in the absence of an inducing agent. In studies to elucidate the role of threonine T38 in CAR regulation, we found that the T38D mutant was inactive even in the presence of CAR activators. However, the T38A mutant was activated by CAR inducers, showing that T38 is not essentialfor CAR activation. Also, using the inhibitor erlotinib, we could not confirm arole for the epidermal growth factor receptor in CAR regulation. Our datasuggest that CAR is constitutively bound to gene regulatory regions and isregulated by exogenous agents through a mechanism which involves proteinphosphorylation in the nucleus.
机译:组成型雄烷烃受体(CAR)是在肝细胞中表达的一种外源生物传感器,可以激活涉及药物代谢,脂质稳态和细胞增殖的基因。在了解药物和异种生物激活人CAR的机制方面已取得了很大进展。然而,激活途径的许多方面仍有待阐明。在本报告中,我们已使用病毒构建体在体外和体内在Car -/-小鼠的肝细胞中表达人CAR,其剪接变体和突变CAR形式。我们证明CAR表达拯救了Car -/-肝细胞对广泛的CAR激活剂(包括苯巴比妥)作出反应的能力。此外,人类CAR的两个主要剪接亚型CAR2和CAR3对几乎所有受试药物均无活性。与当前的CAR激活模型相反,异位CAR1组成型地位于细胞核中,并且在没有诱导剂的情况下被加载到Cyp2b10基因上。在阐明苏氨酸T38在CAR调控中的作用的研究中,我们发现T38D突变体即使在存在CAR激活剂的情况下也没有活性。但是,T38A突变体被CAR诱导剂激活,表明T38不是必需的用于激活CAR。此外,使用抑制剂厄洛替尼,我们无法确认表皮生长因子受体在CAR调节中的作用我们的数据提示CAR在结构上与基因调控区结合,并且通过涉及蛋白质的机制受外源因子调节核中的磷酸化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号